Corify Gave Additional Beats to the Heart with its ‘Whole-Heart Mapping Technology

Introduction

Corify Care, another enthusiast, a MedTech startup flaunting its non-invasive cardiac mapping, is playing a convincing role in enhancing the treatments and diagnosis of cardiac arrhythmias, mainly atrial fibrillation (AF). The leading product of the company is ACORYS®Mapping System, which gives a precise and clear 3D view of the heart’s mechanisms to zoom into the activities closely. The company entered the healthcare spectrum during the spin-off of the Hospital Universitario Gregorio Marañón and Universitat Politécnica de Valencia.

Announcement

Corify Care took the honor to introduce its exclusive Global Volumetric Mapping technology, which speaks about the progress the company has made in cardiac electrophysiology. This announcement represents the first-ever system to ramp and to further prove its ability to map the whole heart. This will ease the physician's responsibility, as this new technology gives a real-time and full view of arrhythmias. This innovation is ahead of its time because there’s no such solution yet discovered in the healthcare market.

Difference

The mapping systems, especially for heart covers only one chamber at a time, which works like a disturbing and time-consuming task for clinicians. The need for quick study analysis delays the reports and thus affects patient care. The real-time real-solution is the continuous efforts of many healthcare-tech giants, but Corify steps ahead, making it into action and figuring out the needs of clinicians and physicians.

The technology graph is at its peak with this tech innovation, the high quality visulaization spans a clear picture of quick treatment and health recovery. Because of this new technology, the arrhythmia activities can be captured covering the heart surface and all chambers during and before ablation.

Apart from this launch, the company also unveiled certain arrhythmia pathways that are not detected using the conventional tools. Because of this, the physicians find it hard to recognise serious heart conditions. Corify’s technology enable to take an intensified tour of each heart wall.

Chief Medical Officer, MD, PhD, Felipe Atienza, said, “This will be the first time anyone sees the heart’s behaviour non-invasively. This has significant implications for outcomes, scalability and workflow in EP labs.”

CEO of Corify Care, PhD, Andreu Climent, said, “This tech innovation is about confidence and visibility. With this, we are giving the full picture of the heart and not any fragments. The precise and full view will elevate fast decisions, alleviate procedure time and more apt ablations.”